HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.53
Day range
$0.52 - $0.54
Year range
$0.27 - $0.82
Market cap
568.72M USD
Avg Volume
799.33K
P/E ratio
43.61
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 36.32M | 92.38% |
Operating expense | 5.86M | 24.34% |
Net income | 13.70M | 224.16% |
Net profit margin | 37.73 | 164.55% |
Earnings per share | — | — |
EBITDA | 8.61M | 120.44% |
Effective tax rate | 12.67% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.62M | 178.57% |
Total assets | 117.25M | 32.94% |
Total liabilities | 55.66M | 35.99% |
Total equity | 61.58M | — |
Shares outstanding | 1.07B | — |
Price to book | 8.79 | — |
Return on assets | 17.97% | — |
Return on capital | 33.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 13.70M | 224.16% |
Cash from operations | 5.10M | 250.37% |
Cash from investing | -103.33K | -688.63% |
Cash from financing | -116.47K | 63.68% |
Net change in cash | 4.88M | 323.37% |
Free cash flow | 2.39M | 497.77% |
About
Founded
1997
Headquarters
Website
Employees
68
